McDermott U - Search Results

1

Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.

Maxwell PJ, Longley DB, Latif T, Boyer J, Allen W, Lynch M, McDermott U, Harkin DP, Allegra CJ, Johnston PG. Maxwell PJ, et al. Among authors: mcdermott u. Cancer Res. 2003 Aug 1;63(15):4602-6. Cancer Res. 2003. PMID: 12907638

2

The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.

Longley DB, Boyer J, Allen WL, Latif T, Ferguson PR, Maxwell PJ, McDermott U, Lynch M, Harkin DP, Johnston PG. Longley DB, et al. Among authors: mcdermott u. Cancer Res. 2002 May 1;62(9):2644-9. Cancer Res. 2002. PMID: 11980662

3

Predictive markers for colorectal cancer: current status and future prospects.

Longley DB, McDermott U, Johnston PG. Longley DB, et al. Among authors: mcdermott u. Clin Colorectal Cancer. 2003 Feb;2(4):223-30. doi: 10.3816/CCC.2003.n.003. Clin Colorectal Cancer. 2003. PMID: 12620141 Review.

4

The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites.

Longley DB, Allen WL, McDermott U, Wilson TR, Latif T, Boyer J, Lynch M, Johnston PG. Longley DB, et al. Among authors: mcdermott u. Clin Cancer Res. 2004 May 15;10(10):3562-71. doi: 10.1158/1078-0432.CCR-03-0532. Clin Cancer Res. 2004. PMID: 15161716

5

Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer.

McDermott U, Longley DB, Galligan L, Allen W, Wilson T, Johnston PG. McDermott U, et al. Cancer Res. 2005 Oct 1;65(19):8951-60. doi: 10.1158/0008-5472.CAN-05-0961. Cancer Res. 2005. PMID: 16204068

6

Clinical significance of prognostic and predictive markers in colorectal cancer.

Longley DB, McDermott U, Johnston PG. Longley DB, et al. Among authors: mcdermott u. Pharmacogenomics J. 2002;2(4):209-16. doi: 10.1038/sj.tpj.6500124. Pharmacogenomics J. 2002. PMID: 12196910 Review. No abstract available.

7

Molecular and biochemical markers in colorectal cancer.

McDermott U, Longley DB, Johnston PG. McDermott U, et al. Ann Oncol. 2002;13 Suppl 4:235-45. doi: 10.1093/annonc/mdf665. Ann Oncol. 2002. PMID: 12401696 Free article. Review. No abstract available.

8

c-FLIP inhibits chemotherapy-induced colorectal cancer cell death.

Longley DB, Wilson TR, McEwan M, Allen WL, McDermott U, Galligan L, Johnston PG. Longley DB, et al. Among authors: mcdermott u. Oncogene. 2006 Feb 9;25(6):838-48. doi: 10.1038/sj.onc.1209122. Oncogene. 2006. PMID: 16247474

9

Prognostic significance of TRAIL signaling molecules in stage II and III colorectal cancer.

McLornan DP, Barrett HL, Cummins R, McDermott U, McDowell C, Conlon SJ, Coyle VM, Van Schaeybroeck S, Wilson R, Kay EW, Longley DB, Johnston PG. McLornan DP, et al. Among authors: mcdermott u. Clin Cancer Res. 2010 Jul 1;16(13):3442-51. doi: 10.1158/1078-0432.CCR-10-0052. Epub 2010 Jun 22. Clin Cancer Res. 2010. PMID: 20570920 Free PMC article.

10

In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer.

Malla SB, Fisher DJ, Domingo E, Blake A, Hassanieh S, Redmond KL, Richman SD, Youdell M, Walker SM, Logan GE, Chatzipli A, Amirkhah R, Humphries MP, Craig SG, McDermott U, Seymour MT, Morton DG, Quirke P, West NP, Salto-Tellez M, Kennedy RD, Johnston PG, Tomlinson I, Koelzer VH, Campo L, Kaplan RS, Longley DB, Lawler M, Maughan TS, Brown LC, Dunne PD; S:CORT consortium. Malla SB, et al. Among authors: mcdermott u. Clin Cancer Res. 2021 Jan 1;27(1):288-300. doi: 10.1158/1078-0432.CCR-20-3237. Epub 2020 Oct 7. Clin Cancer Res. 2021. PMID: 33028592 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters